Oncology
 |
|
22 august 2019 09:03:10 |
| FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients (British Journal of Cancer) |
|
Tweet |
| 205 viewsCategory: Oncology |
 Skp2-mediated ubiquitination and mitochondrial localization of Akt drive tumor growth and chemoresistance to cisplatin (Oncogene)Delivering to the wrong address (Nature Reviews Cancer) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
